[1]
H. AKALAN, D. YASAR SIRIN, M. I. TITIZ, and T. BİLGEN, “CD21 Ligands Provide Better Antibody Specific Response Than The Polyclonal Stimulation in mBCs Activation”, GNJ, vol. 9, no. 4, pp. 510–517, Nov. 2024.